Angela Damato

10PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 25, 2026
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial.

Angela Damato, Riziero Esposito Abate, Simona Tessitore

|Sep 09, 2025
Diagnostic and therapeutic appropriateness in different stages of esophageal/GEJ cancers. The FICOG project.

Carmine Pinto, Carlo Castoro, Ferdinando De Vita

|Nov 27, 2024
Impact of Multidisciplinary Team Management on Survival and Recurrence in Stage I-III Colorectal Cancer: A Population-Based Study in Northern Italy.

Lucia Mangone, Maurizio Zizzo, Melissa Nardecchia

|Jul 13, 2024
Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy.

Lucia Mangone, Francesco Marinelli, Isabella Bisceglia

|Jan 21, 2023
Abdominal Fat Characteristics and Mortality in Rectal Cancer: A Retrospective Study.

Massimo Pellegrini, Giulia Besutti, Marta Ottone

|Aug 26, 2022
New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer.

Angela Damato, Martina Rotolo, Francesco Caputo

Pageof 2

Frequent Collaborators

6 joint publications

Carmine Pinto

2 joint publications

Isabella Bisceglia

2 joint publications

Paolo Giorgi Rossi

2 joint publications

Maurizio Zizzo